Clinical Trials Browser

Phase 1/2 × vinflunine × Clear all

NCT02845050 2018-02-13

JaNEO

Phase 1/2 Withdrawn

Urinary Bladder Neoplasms

NCT01265940 2012-10-10

Pazopanib and Vinflunine in Urothelial Cancer of the Bladder

Phase 1/2 Completed

Urinary Bladder Neoplasms